1. Home
  2. SLN vs HAFC Comparison

SLN vs HAFC Comparison

Compare SLN & HAFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • HAFC
  • Stock Information
  • Founded
  • SLN 1994
  • HAFC 1982
  • Country
  • SLN United Kingdom
  • HAFC United States
  • Employees
  • SLN N/A
  • HAFC N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • HAFC Major Banks
  • Sector
  • SLN Health Care
  • HAFC Finance
  • Exchange
  • SLN Nasdaq
  • HAFC Nasdaq
  • Market Cap
  • SLN 842.4M
  • HAFC 774.8M
  • IPO Year
  • SLN N/A
  • HAFC 1996
  • Fundamental
  • Price
  • SLN $12.70
  • HAFC $25.65
  • Analyst Decision
  • SLN Strong Buy
  • HAFC Buy
  • Analyst Count
  • SLN 4
  • HAFC 6
  • Target Price
  • SLN $61.50
  • HAFC $22.63
  • AVG Volume (30 Days)
  • SLN 184.3K
  • HAFC 251.6K
  • Earning Date
  • SLN 11-14-2024
  • HAFC 10-22-2024
  • Dividend Yield
  • SLN N/A
  • HAFC 3.90%
  • EPS Growth
  • SLN N/A
  • HAFC N/A
  • EPS
  • SLN N/A
  • HAFC 2.08
  • Revenue
  • SLN $21,773,221.00
  • HAFC $232,767,000.00
  • Revenue This Year
  • SLN N/A
  • HAFC N/A
  • Revenue Next Year
  • SLN $104.98
  • HAFC $11.40
  • P/E Ratio
  • SLN N/A
  • HAFC $12.33
  • Revenue Growth
  • SLN N/A
  • HAFC N/A
  • 52 Week Low
  • SLN $8.94
  • HAFC $14.45
  • 52 Week High
  • SLN $27.72
  • HAFC $26.30
  • Technical
  • Relative Strength Index (RSI)
  • SLN 15.31
  • HAFC 68.06
  • Support Level
  • SLN $17.11
  • HAFC $25.06
  • Resistance Level
  • SLN $18.24
  • HAFC $26.07
  • Average True Range (ATR)
  • SLN 0.89
  • HAFC 0.76
  • MACD
  • SLN -0.49
  • HAFC 0.11
  • Stochastic Oscillator
  • SLN 1.06
  • HAFC 84.81

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

About HAFC Hanmi Financial Corporation

Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. Hanmi also offers trade-finance products. The bank has several lending offices outside California and plans to expand outside the state mainly through acquisitions. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.

Share on Social Networks: